InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Year-over-year operating income growth rate
5Y CAGR
-25.6%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineStable
| Period | Value |
|---|---|
| 2025 | 2.66% |
| 2024 | 2.92% |
| 2023 | 39.25% |
| 2022 | -13.32% |
| 2021 | -33.01% |
| 2020 | 11.66% |
| 2019 | -52.83% |
| 2018 | -97.07% |
| 2017 | -87.19% |
| 2016 | 46.81% |